Clinical trial
Observational Study of Superstat® (Rosuvastatin) in Hypercholesterolemia Patients in Lebanon
NCT03516955 is registered in ClinicalTrials.gov with Hikma Pharmaceuticals LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Study of Superstat® (Rosuvastatin) in Hypercholesterolemia Patients in Lebanon
- Lead sponsor
- Hikma Pharmaceuticals LLC
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2014
- Completion date
- August 31, 2015
- Enrollment
- 317 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
primary hypercholesterolemia